Breaking News
Get 50% Off 0
🏄 Grow your portfolio even on vacation with InvestingPro | Summer Sale 50% OFF
CLAIM SALE
Close

Rohto Pharmaceutical (4527)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2,486.5 -13.5    -0.54%
07:30:29 - Closed. Currency in JPY
Type:  Equity
Market:  Japan
ISIN:  JP3982400008 
  • Volume: 1,886,400
  • Bid/Ask: 2,486.0 / 2,497.0
  • Day's Range: 2,470.0 - 2,523.0
Rohto Pharmaceutical 2,486.5 -13.5 -0.54%

Rohto Pharmaceutical Company Profile

 
Get an in-depth profile of Rohto Pharmaceutical, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

7176

Equity Type

ORD

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatological, gastrointestinal, and diagnostic drugs, as well as Chinese herbal medicines, and supplements. In addition, the company operates beauty counters that provide beauty and health services; and manufactures and sells diagnostic reagents, as well as provides investment management services; and contract development and manufacturing services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.

Contact Information

Address 1-8-1, Tatsumi-nishi Ikuno-ku
Osaka, 544-8666
Japan
Phone 81 6 6758 1231
Fax -

Top Executives

Name Age Since Title
Yamada Kunio 69 1999 Chairman of the Board
Masae Yamanaka 62 2024 Chief Transformation Officer & Director
Shinichi Kunisaki 70 2010 Executive VP, CTO & Director
Shoichiro Iwata 75 2025 Independent Outside Director
Yasunori Kawasaki 65 2023 Chief Human Resources Officer & Director
Yoichi Honma 57 2024 Chief Scientific Officer & Director
Eri Sugiyama 50 2024 Outside Audit & Supervisory Board Member
Yasuhiro Tani 69 2020 Outside Auditor
Haruka Mera 38 2020 Independent Outside Director
Kimura Masanori 68 2005 Standing Corporate Auditor
Hideto Uemura 67 2020 Full-Time Auditor
Maiko Katadae 50 2024 Independent Outside Director
Eriko Hayashi 49 2022 Independent Outside director
Akie Iriyama 53 2019 Independent Outside Director
Hidetoshi Segi 63 2018 COO, President & Representative Director
Yoko Fujimoto 60 2025 MD, Chief Medical Officer & Director
Asuka Terada 51 2025 Outside Auditor
Noriko Suenobe 59 2025 Chief Research Officer & Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4527 Comments

Write your thoughts about Rohto Pharmaceutical
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email